SEBETRALSTAT EFFECTIVENESS IN THE TREATMENT OF HEREDITARY ANGIOEDEMA ATTACKS RATED MILD OR MODERATE AT BASELINE IN THE PHASE 2 TRIAL

Longhurst, H.J., Smith, M.D., Yea, C. et al. (1 more author) (2022) SEBETRALSTAT EFFECTIVENESS IN THE TREATMENT OF HEREDITARY ANGIOEDEMA ATTACKS RATED MILD OR MODERATE AT BASELINE IN THE PHASE 2 TRIAL. In: INTERNAL MEDICINE JOURNAL. 32nd Annual Conference of the Australasian Society of Clinical Immunology and Allergy (ASCIA), 30 Aug - 02 Sep 2022, Melbourne, Australia. , p. 29.

Metadata

Item Type: Proceedings Paper
Authors/Creators:
  • Longhurst, H.J.
  • Smith, M.D.
  • Yea, C.
  • Audhya, P.
Dates:
  • Published: 2 October 2022
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 07 Oct 2024 14:51
Last Modified: 07 Oct 2024 14:51
Status: Published
Identification Number: 10.1111/imj.94_15894
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics